Navigation Links
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Date:8/19/2007

tients and only by healthcare professionals who are knowledgeable of and skilled in the use of Schedule II opioids to treat cancer pain.

The concomitant use of FENTORA with strong and moderate cytochrome P450 3A4 inhibitors may result in an increase in fentanyl plasma concentrations, and may cause potentially fatal respiratory depression.

Full prescribing information about FENTORA, including boxed warning, is available from http://www.FENTORA.com.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. Cephalon has delivered a seven-year compound annual growth rate (CAGR) through 2006 greater than 75 percent and 2006 revenue of $1.760 billion. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA, TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current
'/>"/>

SOURCE Cephalon, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...e-USNewswire/ -- Jupiter Medical Center has inco... available into its imaging program, the new Signa...m delivers highly detailed images of the human bod...ue applications, including dual breast scanning an...renal dysfunction. This results in shorter exams ...
(Date:12/2/2009)... Laser Spine Institute (LSI), the leader in mini...unce a partnership with United Healthcare and affi...nd clinical review process. Laser Spine Institute ...vasive spinal surgery to ever contract with United...United Healthcare may be covered for qualified nec...
(Date:12/2/2009)...ire-FirstCall/ -- American Scientific Resources ,... that the Disintegrator Plus(TM), the world,s only..., is in its first production run for ASR. ,, S...r home injection prescription drug users in Califo... 486 which requires Californian,s to safely dispo...
Breaking Medicine Technology:Jupiter Medical Center Announces New High-Definition MRI System 2Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3Addus HomeCare Corporation Files Registration Statement 52015 1Addus HomeCare Corporation Files Registration Statement 52015 2Great Expressions Dental Centers Inc Offers Free Membership and Up to 35 25 Off Dental Care With the Great Expressions Smile Protection Program 52010 1Great Expressions Dental Centers Inc Offers Free Membership and Up to 35 25 Off Dental Care With the Great Expressions Smile Protection Program 52010 2Five Hypertension Genes Found in Black Americans 52006 1Five Hypertension Genes Found in Black Americans 52006 2Five Hypertension Genes Found in Black Americans 52006 3
..., Dec. 27 According to the latest,science, resver...t doses of,resveratrol plus an array of antioxidan...s of aged, red wine, rather than resveratrol alone...rnh/20080603/LATU039 ) , The most recent stud...ng,the life of laboratory mice. In fact, mega-dos...
...omplex of Its Kind; 80 Percent of Trauma Patient,s...multi-disciplinary team of doctors and surgeons at...r-total face transplant in the United States. , ... past two weeks, surgeons transplanted 80 percent ...a -- essentially replacing her entire face, except...
Other Medicine Technology:Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 /PRNewswire-USNewswir...ctor and CEO, Natural Products Association ,, ...he U.S. Anti-Doping Agency (USADA) to educate cons... selling steroids as dietary supplements, the Natu...rade association representing retailers and manufa...
(Date:12/2/2009)...tudy finds rising incidence of obesity could count...NESDAY, Dec. 2 (HealthDay News) -- The overall hea...ast three decades, largely because people have qui...e gains might soon be wiped out if the rising obes... , If current trends in both smoking and obesit...
(Date:12/2/2009)...3 added batches now available, many more to come, ...2 (HealthDay News) -- Thirteen stem cell lines ha...for taxpayer-funded research, and many more such l...cials announced Wednesday. , These are the firs...r research funded by the U.S. National Institutes ...
(Date:12/2/2009)..., , WHITE PLAINS, N.Y., Dec. 2 /PRNewswire...will present their findings in blood cancer resear...SH) conference in New Orleans December 4-8, 2009. ... & Lymphoma Society (LLS) experts, including C...nior Vice President of Patient Services Hildy Dill...
(Date:12/2/2009)..., , PHILADELPHIA, Dec. 2 I...ew health benefits contract with Lincoln Financial... insurance for approximately 10,000 Lincoln Financ...s across the nation. The Lincoln plan offerings wi...Medical plans. ,, "I know I speak for all of us...
Breaking Medicine News(10 mins):Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3
...men living near Seveso disaster were 6 times more ..., FRIDAY, Aug. 1 (HealthDay News) -- Women who 32 ...l in Italy have been six times more likely to give...e , looks at the aftereffect of an accidental rele...
...actures, sprains and strains result from ignoring ...ATURDAY, Aug. 2 (HealthDay News) -- Most people lo... swelter, but don,t let that refreshing feeling ma...imming-related injuries, including fractures, stra...
... LegalView updated its tra... a request for research by the Department of Veter...d with soldiers and helmets. The VA has declared t... Denver, CO (PRWEB) August 2,...
...SHINGTON, Aug. 1 A report released yesterday by t... Pesticides," distorts the,truth about the health ...ccording to the Consumer Specialty Products Associ... system related to,pyrethrins, natural insecticide...
...SHINGTON, Aug. 1 The federal Centers for,Disease ...vised estimate of,annual new cases of HIV infectio... in the Journal of the American Medical Associatio...cs portray.,The revised estimate for 2006 will rep...
...DEO ALERT: B-roll is available through Pathfire,s ... advisory for details., ROCHESTER, Minn., Aug. 1 ...h.D., has continued his research in,environment-ch...ity thermogenesis). The study began in late 2007 a...
Other Medicine News:Health News:Orthopedic Surgeons Weigh in on Pool Safety 2Health News:LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 2Health News:LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers 3Health News:New Report Distorts Truth About Pesticides 2Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 2Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 3Health News:'Office of the Future' Environment Study 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: